• 836 Citations
  • 14 Scopus h-Index
20122020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 836 Citations
  • 14 Scopus h-Index
  • 43 Article
  • 13 Letter
  • 12 Review article
  • 3 Comment/debate
Filter
Review article
2018

Clinical presentation of autoimmune and viral encephalitides

Dubey, D., Toledano, M. & McKeon, A., Apr 1 2018, In : Current Opinion in Critical Care. 24, 2, p. 80-90 11 p.

Research output: Contribution to journalReview article

5 Scopus citations
2017

B-cell-Targeted therapies in relapsing forms of MS

Dubey, D., Forsthuber, T., Flanagan, E., Pittock, S. J. & Stüve, O., Oct 23 2017, In : Neurology: Neuroimmunology and NeuroInflammation. 4, 6, e405.

Research output: Contribution to journalReview article

5 Scopus citations

Gradually progressive spastic ataxia in a young man steadily unsteady

Dubey, D., Khemani, P., Remster, E. & Elliott, J. L., Feb 1 2017, In : JAMA neurology. 74, 2, p. 238-241 4 p.

Research output: Contribution to journalReview article

2 Scopus citations
2016

Diagnostic and therapeutic strategies for management of autoimmune encephalopathies

Dubey, D., Blackburn, K., Greenberg, B., Stuve, O. & Vernino, S., Aug 2 2016, In : Expert review of neurotherapeutics. 16, 8, p. 937-949 13 p.

Research output: Contribution to journalReview article

14 Scopus citations

Managing Disability in Progressive Multiple Sclerosis

Dubey, D., Sguigna, P. & Stüve, O., Jun 1 2016, In : Current Treatment Options in Neurology. 18, 6, 27.

Research output: Contribution to journalReview article

3 Scopus citations

Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis

Dubey, D., Cano, C. A. & Stüve, O., Jun 1 2016, In : Current opinion in neurology. 29, 3, p. 278-285 8 p.

Research output: Contribution to journalReview article

17 Scopus citations
6 Scopus citations

Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: Case report and review of literature

Dubey, D., Zhang, Y., Graves, D., DeSena, A. D., Frohman, E. & Greenberg, B., May 1 2016, In : Therapeutic Advances in Neurological Disorders. 9, 3, p. 211-215 5 p.

Research output: Contribution to journalReview article

8 Scopus citations
2015

Dimethyl fumarate in relapsing-remitting multiple sclerosis: Rationale, mechanisms of action, pharmacokinetics, efficacy and safety

Dubey, D., Kieseier, B. C., Hartung, H. P., Hemmer, B., Warnke, C., Menge, T., Miller-Little, W. A. & Stuve, O., Apr 1 2015, In : Expert review of neurotherapeutics. 15, 4, p. 339-346 8 p.

Research output: Contribution to journalReview article

40 Scopus citations

Intractable and highly active relapsing multiple sclerosis – Role of alemtuzumab

Dubey, D., Cano, C. A. & Stuve, O., Sep 18 2015, In : Neuropsychiatric Disease and Treatment. 11, p. 2405-2414 10 p.

Research output: Contribution to journalReview article

8 Scopus citations
2014

Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: Approved therapies and emerging candidates

Dubey, D., Kieseier, B. C., Hartung, H. P., Hemmer, B., Miller-Little, W. A. & Stuve, O., Jan 1 2014, In : Expert Review of Clinical Immunology. 11, 1, p. 93-108 16 p.

Research output: Contribution to journalReview article

13 Scopus citations

Para-dichlorobenzene toxicity - a review of potential neurotoxic manifestations

Dubey, D., Sharma, V. D., Pass, S. E., Sawhney, A. & Stuve, O., Jan 1 2014, In : Therapeutic Advances in Neurological Disorders. 7, 3, p. 177-187 11 p.

Research output: Contribution to journalReview article

Open Access
8 Scopus citations